CORD-19:8c51cf0cc444f6a851ad178040369984759ddfec / 22185-22368
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/8c51cf0cc444f6a851ad178040369984759ddfec","sourcedb":"CORD-19","sourceid":"8c51cf0cc444f6a851ad178040369984759ddfec","text":"The patient sera contained anti-GAD antibodies, which reacted with GABA-ergic retinal structures, suggesting that this reactivity may be associated with the ophthalmic manifestations.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T181","span":{"begin":0,"end":183},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T181","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T81","span":{"begin":0,"end":183},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T81","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T181","span":{"begin":0,"end":183},"obj":"Sentence"}],"attributes":[{"subj":"T181","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T183","span":{"begin":32,"end":35},"obj":"Disease"},{"id":"T83438","span":{"begin":32,"end":35},"obj":"Disease"}],"attributes":[{"id":"A183","pred":"mondo_id","subj":"T183","obj":"http://purl.obolibrary.org/obo/MONDO_0001942"},{"id":"A42895","pred":"mondo_id","subj":"T83438","obj":"http://purl.obolibrary.org/obo/MONDO_0001942"},{"subj":"T183","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T83438","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#a493ec","default":true},{"id":"Epistemic_Statements","color":"#9cec93"},{"id":"CORD-19_Custom_license_subset","color":"#ec93b6"},{"id":"CORD-19-PD-MONDO","color":"#93d0ec"}]}]}}